Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication approved for attention deficit hyperactivity disorder in children and grown-ups . In Canada, its access is overseen by Health Canada. This https://order-sandoz-lisdexamfet605734.theroseblog.com/582619/lisdexamfetamine-in-canada-a-complete-guide